Effects of ABCA1 gene polymorphisms on risk factors, susceptibility and severity of coronary artery disease

Zhan Lu1, Zhi Luo1, Aimei Jia2

  • 1Department of Cardiology, Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan, China.

Insights

The rs1800976 polymorphism in ATP binding cassette protein A1 is linked to coronary artery disease (CAD) occurrence and severity. This association may involve high-sensitivity C-reactive protein (hs-CRP) and cystatin C (CysC) levels.

Area of Science:

  • Genetics and Cardiovascular Disease Research
  • Molecular Biology and Disease Mechanisms

Background:

  • The genetic factors influencing coronary artery disease (CAD) severity are not fully understood.
  • The role of specific ATP binding cassette protein A1 (ABCA1) gene polymorphisms (rs1800976, rs4149313, rs2230806) in CAD remains unclear.

Purpose of the Study:

  • To investigate the association between ABCA1 gene polymorphisms (rs1800976, rs4149313, rs2230806) and the severity of coronary artery disease (CAD).
  • To explore potential biomarkers, such as hs-CRP and CysC, involved in this relationship.

Main Methods:

  • Genotyping of ABCA1 polymorphisms (rs1800976, rs4149313, rs2230806) using PCR-RFLP in 442 CAD patients and 217 controls.
  • Assessment of CAD severity using Gensini score, number of stenotic vessels, and extent of stenosis.
  • Measurement of biochemical markers including hs-CRP, CysC, total cholesterol, LDL-C, and uric acid.

Main Results:

  • The C allele of rs1800976, G allele of rs4149313, and A allele of rs2230806 were identified as risk alleles for CAD.
  • The rs1800976 polymorphism (C allele) was significantly associated with increased CAD severity markers and elevated hs-CRP and CysC levels.
  • While rs4149313 and rs2230806 genotypes correlated with lipid profiles and uric acid, they did not show association with CAD severity.

Conclusions:

  • The rs1800976 polymorphism in the ABCA1 gene is a significant risk factor for both the occurrence and severity of coronary artery disease.
  • Elevated levels of hs-CRP and CysC may mediate the association between the rs1800976 polymorphism and CAD severity.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
813
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
545
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
313
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
281
Human Genetics01:28

Human Genetics

Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
1.3K
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
710